Technology | Population Health | April 03, 2015

PatientPoint Population Health Management Application Receives Meaningful Use Certification

Software provides automated outreach from physicians to patients

April 3, 2015 — PatientPoint announced that PatientPoint Outreach 3.2 is now certified for Meaningful Use in an ambulatory setting. The software is also compliant with the Office of the National Coordinator (ONC) 2014 Edition criteria for certified electronic health record technology (CEHRT).

The ONC 2014 Edition criteria supports both Stage 1 and Stage 2 Meaningful Use measures that are required to qualify eligible providers for funding under the American Recovery and Reinvestment Act (ARRA).

PatientPoint Outreach 3.2 provides trusted and secure communications on behalf of the physician, and is highly customizable to a provider’s goals. By helping to manage patient adherence and follow-up, it can play a key role in improving clinical outcomes throughout the care continuum.

Driven by a population health analytics engine, the software provides automated outreach by email, text and interactive voice response (IVR), depending on the patient's stated preference. Eligible providers can submit against the Stage 1 and Stage 2 criteria for patient list creation and patient reminders.

PatientPoint Outreach 3.2 was certified by the Certification Commission for Health Information Technology (CCHIT) in accordance with the applicable Eligible Provider certification criteria adopted by the Secretary of Health and Human Services. PatientPoint certification (#IG-3251-15-0016) meets the following criteria:

  • 170.314(a)(14) Patient List Creation and Reminders
  • 170.314(g)(2) Automated Measures
  • 170.314(g)(4) Quality Management System

 

The application was certified by Infogard, an Accredited Testing Laboratory (NVLAP Lab Code: 100432-0) and ONC-Authorized Certification Body to test and certify Electronic Health Record (EHR) products for the ONC HIT Certification Program. InfoGard provides information technology services for organizations within the healthcare, financial, and federally mandated markets.

For more information: www.patientpoint.com


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now